Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises? Stella PapachristouDjordje S. PopovicNikolaos Papanas Editorial 28 March 2022 Pages: 2283 - 2286
Proposal for a New Protocol for the Management of Immune Thrombocytopenia (ITP) Tomás José González-LópezDrew Provan Commentary 07 April 2022 Pages: 2287 - 2291
Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK Julian D. GillmoreMary M. ReillyPhilip N. Hawkins Commentary Open access 13 April 2022 Pages: 2292 - 2301
Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective Mohit BhutaniDavid B. PriceJohn R. Hurst Commentary Open access 28 April 2022 Pages: 2302 - 2322
Improving Care in Eosinophil-Associated Diseases: A Charter David J. JacksonPraveen AkuthotaTonya Winders Commentary Open access 30 April 2022 Pages: 2323 - 2341
Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era Stefan SchreiberShomron Ben-HorinWalter Reinisch Review Open access 06 January 2022 Pages: 2342 - 2364
A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma Dominic BrittainPeter D’AndreaHanns-Christian Tillmann Review Open access 24 January 2022 Pages: 2365 - 2378
The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours Fernando LĂłpezJatin P. ShahAlfio Ferlito Review Open access 30 March 2022 Pages: 2379 - 2397
Advances in Clinical Cardiology 2021: A Summary of Key Clinical Trials Patrick SavageBrian CoxIan Menown Review Open access 28 April 2022 Pages: 2398 - 2437
Iron Deficiency in Women’s Health: New Insights into Diagnosis and Treatment Christina M. Moisidis-TeschLee P. Shulman Review 30 April 2022 Pages: 2438 - 2451
Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review Mojca JensterleManfredi RizzoAndrej JaneĹľ Review 03 May 2022 Pages: 2452 - 2467
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study Johan DalénAnushri ChitkaraZaina P. Qureshi Original Research Open access 09 November 2021 Pages: 2468 - 2486
Correction to: Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study Johan DalénAnushri ChitkaraZaina P. Qureshi Publisher Correction 03 March 2022 Pages: 2487 - 2488
What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine A. Elif MĂĽderrisogluMatthias OelkeMartin C. Michel Original Research Open access 24 March 2022 Pages: 2489 - 2501
Epidemiology and Economic Burden of Atopic Dermatitis: Real-World Retrospective Data from a Large Nationwide Israeli Healthcare Provider Database Clara WeilPhilip B. SugermanYael A. Leshem Original Research Open access 29 March 2022 Pages: 2502 - 2514
Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents Jason M. HafronHelen M. WilfehrtRana R. McKay Original Research Open access 30 March 2022 Pages: 2515 - 2532
Occurrence and Prognosis of Secondary Lung Cancer in Patients with Primary Nasal Cavity and Sinus Squamous Cell Carcinoma Jing FengGang JinXiang Song Original Research 31 March 2022 Pages: 2533 - 2543
Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer Daniel SimmonsStephanie V. BlankKimmie McLaurin Original Research Open access 01 April 2022 Pages: 2544 - 2561
Menstrual Symptoms, Health-Related Quality of Life, and Work Productivity in Japanese Women with Dysmenorrhea Receiving Different Treatments: Prospective Observational Study Osamu YoshinoNoriko TakahashiYoshimi Suzukamo Original Research Open access 01 April 2022 Pages: 2562 - 2577
Treatment Patterns Among Patients with Bipolar Disorder in the United States: A Retrospective Claims Database Analysis Rakesh JainAmanda M. KongAmanda Harrington Original Research Open access 06 April 2022 Pages: 2578 - 2595
Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer Hironaga SatakeYoshinori KagawaAkitaka Makiyama Original Research Open access 06 April 2022 Pages: 2596 - 2613
Pembrolizumab Plus Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A Cost-Effectiveness Analysis Youwen ZhuKun LiuLibo Peng Original Research 08 April 2022 Pages: 2614 - 2629
Real-World Treatment Patterns After CD19-Directed CAR T Cell Therapy Among Patients with Diffuse Large B Cell Lymphoma Jessica J. JalbertNing WuJon E. Arnason Original Research Open access 09 April 2022 Pages: 2630 - 2640
Enzalutamide in Chemotherapy-NaĂŻve Metastatic Castration-Resistant Prostate Cancer: An Asian Multiregional, Randomized Study Yeong-Shiau PuHanjong AhnLi-Ping Xie Original Research Open access 10 April 2022 Pages: 2641 - 2656
Treatment Goals for Psoriasis as Measured by Patient Benefit Index: Results of a National Psoriasis Foundation Survey April ArmstrongEmily Edson-HerediaStacy Smith Original Research Open access 11 April 2022 Pages: 2657 - 2667
Tafasitamab Plus Lenalidomide Versus 3 Rituximab-Based Treatments for Non-Transplant Eligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Matching-Adjusted Indirect Comparison Raul CordobaThibaud PrawitzLorenzo Sabatelli Original Research Open access 11 April 2022 Pages: 2668 - 2687
Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM Yuji KawaguchiShoko MiyamotoYasuro Kumeda Original Research Open access 11 April 2022 Pages: 2688 - 2700
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial Justus G. GarwegJana Ĺ tefanickovathe VIOLET Investigators Original Research Open access 12 April 2022 Pages: 2701 - 2716
Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin–Angiotensin–Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective Barbara FischerAndreas SerraHarry Telser Original Research Open access 13 April 2022 Pages: 2717 - 2730
Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study Denis SmithCĂ´me LepageCatherine Lombard-Bohas Original Research Open access 13 April 2022 Pages: 2731 - 2748
Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart® Injector: Results of the Prospective Cohort Study REBIFLECT Peter RieckmannTjalf ZiemssenUwe K. Zettl Original Research Open access 15 April 2022 Pages: 2749 - 2760
Mesenchymal Stem Cell Therapy Awareness, Knowledge, and Use for the Treatment of Fistulizing Crohn’s Disease: An International Survey Among Gastroenterologists and Colorectal Surgeons Paul WilliamsCatherine KlersyRachele Ciccocioppo Original Research Open access 15 April 2022 Pages: 2761 - 2777
Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate Cancer Mark D. DaneseJennifer SchenfeldGary Lyman Original Research 16 April 2022 Pages: 2778 - 2795
“I Can’t Take off My Shirt or Do My Own Hair”—A Qualitative Investigation of the Symptoms and Impact Experience of Children and Adolescents with Fibrodysplasia Ossificans Progressiva (FOP) Jessica T. MarkowitzDiana RofailPatrick Marquis Original Research Open access 16 April 2022 Pages: 2796 - 2805
Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials Irene E. van der Horst-BruinsmaKurt de VlamMarina Magrey Original Research Open access 16 April 2022 Pages: 2806 - 2819
Unmet Needs of Glycaemic Control and Risk Factors of Residual Hyperglycaemia in a Chinese Population with Type 2 Diabetes Initiating Basal Insulin: A Post Hoc Analysis of the FPG GOAL Study Xin WangGuangyu WuWenying Yang Original Research Open access 16 April 2022 Pages: 2820 - 2830
Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer Types Aracelis Z. TorresNathan C. NussbaumRebecca A. Miksad Original Research Open access 17 April 2022 Pages: 2831 - 2849
Use of Perindopril Arginine/Indapamide/Amlodipine in the Management of Hypertension in Two Sub-Saharan African Island Countries of Madagascar and Mauritius Armand MbanyaAzarkhan AckbarkhanJean Claude Mbanya Original Research Open access 18 April 2022 Pages: 2850 - 2861
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials Sanjay ChabraB. J. GillLuis Puig Original Research Open access 21 April 2022 Pages: 2862 - 2872
The Durable Safety and Effectiveness of Lixisenatide in Japanese People with Type 2 Diabetes: The Post-Marketing Surveillance PRANDIAL Study Yasuo TerauchiMakiko UsamiTomoyuki Inoue Original Research Open access 21 April 2022 Pages: 2873 - 2888
Inflammatory Bowel Disease Patients’ Treatment Preferences Using a Discrete Choice Experiment Technique: The InPuT Study Stefan SchubertNils PickerWolfgang Mohl Original Research Open access 22 April 2022 Pages: 2889 - 2905
Disease Progression Stages and Burden in Patients with Duchenne Muscular Dystrophy Using Administrative Claims Supplemented by Electronic Medical Records Joel IffYi ZhongCINRG DNHS Investigators Original Research 23 April 2022 Pages: 2906 - 2919
Clinicopathologic Characteristics and Prognosis of PDGFRA-Mutant Gastrointestinal Stromal Tumors: A Large-Scale, Multi-Institutional, Observational Study in China Peng ZhangMing WangKaixiong Tao Original Research 24 April 2022 Pages: 2920 - 2931
Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database Philip J. MeasePamela YoungArthur Kavanaugh Original Research Open access 28 April 2022 Pages: 2932 - 2945
High Expression of C8orf76 Is an Independent Predictive Factor of Poor Prognosis in Patients with Breast Cancer Yitong WangXiaoshen Dong Original Research 28 April 2022 Pages: 2946 - 2960
17-Year Follow-up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicenter, Randomized Controlled Trial Chengyu LuoChangsheng WeiYun Yang Original Research 29 April 2022 Pages: 2961 - 2970
Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China Dunming XiaoYue ZhangYingyao Chen Original Research 30 April 2022 Pages: 2971 - 2983
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup Annabelle A. OkadaKanji TakahashiThe ALTAIR Study Investigators Original Research Open access 03 May 2022 Pages: 2984 - 2998
Changes in Refractive Error Under COVID-19: A 3-Year Follow-up Study Xiaoyan YangQian FanYan Wang Original Research Open access 04 May 2022 Pages: 2999 - 3010
Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial Michael DreherChristian GrohèStephan Eisenmann Brief Report Open access 13 April 2022 Pages: 3011 - 3018